These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38873696)

  • 21. Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination.
    Hakroush S; Tampe B
    Front Immunol; 2021; 12():762006. PubMed ID: 34659268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Value of Histologic Classification of ANCA-Associated Glomerulonephritis.
    Bjørneklett R; Sriskandarajah S; Bostad L
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2159-2167. PubMed ID: 27797896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis.
    Boomsma MM; Stegeman CA; Oost-Kort WW; Kallenberg CG; Moguilevsky N; Limburg PC; Tervaert JW
    J Immunol Methods; 2001 Aug; 254(1-2):47-58. PubMed ID: 11406152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Kidney injury molecules (KIM-1, MCP-1) and type IV collagen in the assessment of activity of antineutrophil cytoplasmic antibody-associated glomerulonephritis].
    Bulanov NM; Serova AG; Kuznetsova EI; Bulanova ML; Novikov PI; Kozlovskaya LV; Moiseev SV
    Ter Arkh; 2017; 89(6):48-55. PubMed ID: 28745689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive Analysis of Sex Differences at Disease Manifestation in ANCA-Associated Glomerulonephritis.
    Tampe D; Korsten P; Ströbel P; Hakroush S; Tampe B
    Front Immunol; 2021; 12():736638. PubMed ID: 34630417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients.
    Khalighi MA; Wang S; Henriksen KJ; Bock M; Keswani M; Chang A; Meehan SM
    Pediatr Nephrol; 2015 Jun; 30(6):953-9. PubMed ID: 25669759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome Predictors of Biopsy-Proven Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
    Ge Y; Yang G; Yu X; Sun B; Zhang B; Yuan Y; Zeng M; Wang N; Mao H; Xing C
    Front Immunol; 2020; 11():607261. PubMed ID: 33613528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antineutrophil cytoplasmic antibody negative pauci-immune extracapillary glomerulonephritis.
    Villacorta J; Diaz-Crespo F; Acevedo M; Guerrero C; Mollejo M; Fernandez-Juarez G
    Nephrology (Carlton); 2016 Apr; 21(4):301-7. PubMed ID: 26369898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ANCA-associated vasculitis in scleroderma: A renal perspective
.
    Kant S; Shah AA; Hummers LK; Wigley FM; Geetha D
    Clin Nephrol; 2018 Dec; 90(6):413-418. PubMed ID: 30106367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antineutrophil cytoplasmic antibody-negative pauci-immune crescentic glomerulonephritis associated with rheumatoid arthritis: An unusual case report.
    Hsieh HS; Chang CF; Yang AH; Kuo HL; Yang WC; Lin CC
    Nephrology (Carlton); 2003 Oct; 8(5):243-7. PubMed ID: 15012711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk Factors for Renal Survival in Chinese Patients with Myeloperoxidase-ANCA-Associated GN.
    Chen Y; Bao H; Liu Z; Liu X; Gao E; Zeng C; Zhang H; Liu Z; Hu W
    Clin J Am Soc Nephrol; 2017 Mar; 12(3):417-425. PubMed ID: 28148558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics and outcome of double-seropositive patients with anti-glomerular basement membrane antibodies and anti-neutrophil cytoplasmic antibodies.
    Ge Y; Zhu J; Yang G; Liu K; Yu X; Sun B; Zhang B; Yuan Y; Zeng M; Wang N; Xing C; Mao H
    Int Immunopharmacol; 2024 Sep; 138():112607. PubMed ID: 38981222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of smoldering antineutrophil cytoplasmic antibody-associated vasculitis development during the course of primary Sjögren's syndrome.
    Iwafuchi Y; Morioka T; Oyama Y; Narita I
    CEN Case Rep; 2022 May; 11(2):247-253. PubMed ID: 34787826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN.
    Zhao L; David MZ; Hyjek E; Chang A; Meehan SM
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):54-62. PubMed ID: 25516918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice.
    Hamano Y; Ito F; Suzuki O; Koura M; Matsuoka S; Kobayashi T; Sugitani Y; Wali N; Koyanagi A; Hino O; Suzuki S; Sugamata R; Yoshizawa H; Yumura W; Maruyama N; Kameoka Y; Noda Y; Hasegawa Y; Arai T; Suzuki K
    Autoimmunity; 2019; 52(5-6):208-219. PubMed ID: 31476889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis.
    Menez S; Hruskova Z; Scott J; Cormican S; Chen M; Salama AD; Alasfar S; Little MA; Safrankova H; Honsova E; Tesar V; Geetha D
    Am J Nephrol; 2018; 48(6):465-471. PubMed ID: 30472700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual anti-neutrophil cytoplasmic antibody-related pauci-immune crescentic glomerulonephritis in a patient with Sjögren's syndrome.
    Lee IH; Kim SK; Kim MK
    Rheumatol Int; 2016 Sep; 36(9):1327-34. PubMed ID: 27384449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic Myeloperoxidase Inhibition Attenuates Neutrophil Activation, ANCA-Mediated Endothelial Damage, and Crescentic GN.
    Antonelou M; Michaëlsson E; Evans RDR; Wang CJ; Henderson SR; Walker LSK; Unwin RJ; Salama AD;
    J Am Soc Nephrol; 2020 Feb; 31(2):350-364. PubMed ID: 31879336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-neutrophil cytoplasmic antibodies (ANCA) in the glomerulonephritis].
    Kacprzyk F; Chrzanowski W
    Pol Arch Med Wewn; 1996 Jun; 95(6):514-23. PubMed ID: 9005420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Proteinase 3 versus Myeloperoxidase Positivity on Risk of End-Stage Renal Disease in ANCA-Associated Glomerulonephritis Stratified by Histological Classification: A Population-Based Cohort Study.
    Solbakken V; Fismen AS; Bostad L; Bjørneklett R
    Dis Markers; 2018; 2018():3251517. PubMed ID: 29854025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.